Brain-derived neurotrophic factor and neuropsychiatric disorders

Area of Science:

• Neuroscience
• Psychiatry
• Molecular Biology

Background:

• Brain derived neurotrophic factor (BDNF) is the most abundant growth factor in the central nervous system (CNS).
• BDNF is vital for CNS development, neuronal survival, and synaptic plasticity.
• Dysregulation of BDNF is implicated in various neurological and psychiatric conditions.

Purpose of the Study:

• To review clinical and preclinical evidence linking BDNF to major depressive disorder, schizophrenia, addiction, and Rett syndrome.
• To discuss BDNF's role in the mechanism of action of current psychiatric pharmacotherapies.
• To evaluate experimental therapies and BDNF's potential as a future drug target.

Main Methods:

• Comprehensive literature review of clinical and preclinical studies.
• Analysis of existing data on BDNF's involvement in psychiatric and neurodevelopmental diseases.
• Examination of pharmacological and experimental therapeutic strategies targeting BDNF.

Main Results:

• Significant evidence supports BDNF's involvement in the pathophysiology of major psychiatric disorders.
• BDNF influences the efficacy of antidepressants and antipsychotics.
• Experimental therapies like BDNF mimetics show promise but require further investigation.

Conclusions:

• BDNF is a key player in brain function and a significant factor in psychiatric illness.
• Targeting BDNF offers a promising avenue for novel therapeutic strategies in CNS disorders.
• Further research is warranted to fully elucidate BDNF's therapeutic potential.